Search
Close this search box.

Prodiet Closed System Line.
Vital for care.

An intelligent solution, from the ICU to the hospital ward.

You who are on the front line of hospital care know that every choice makes a difference. Offering complete and effective nutritional solutions for your patients is one of them.

Developed with all Prodiet's expertise in enteral diets, the Closed System Line has everything it takes to bring countless benefits to hospitals, healthcare professionals and patients.

Produced in Brazil. Active technical support.

Material for health professionals

There are 3 exclusive formulas.
Vital for the care of different
clinical profiles 1-37

Trophic 1.5 Fiber RTH 1L

Ideal for patients with intestinal disorders. High-calorie formula with soluble and insoluble fibers.

Trophic 1.5 Protein RTH 1L

Ideal for patients with high calorie and protein needs. Hypercaloric and hyperprotein formula.

DIAMax IG RTH

Ideal for patients with diabetes or hyperglycemia. Normocaloric formula with a low glycemic index.

Spun

Connected

Hanging

The Prodiet Closed System is exclusive use with Enplus equipment and infusion pump administration.

What makes the Prodiet Closed System vital
for hospital care?

The Closed System Line is a strategic choice that combines efficiency, cost predictability and clinical performance. Produced in Brazil, it guarantees agile replenishment and eliminates the risk of shortages, as well as offering technical support to medical teams

CLOSE AND ACCESSIBLE TECHNICAL SUPPORT

ensuring continuity and quality of care.

STRATEGIC CHOICE FOR HOSPITALS SEEKING EFFICIENCY

cost predictability and clinical performance.

SOLIDITY OF A LEADING NATIONAL BRAND,

committed to nutritional care.

COMPREHENSIVE PATIENT FOLLOW-UP

the ICU at discharge, with consistent clinical results.

PRODUCED IN BRAZIL

guaranteeing rapid replenishment and eliminating the risk of shortages.

SOLUTIONS THAT COMBINE SCIENCE AND OPERATIONAL EFFICIENCY

for the hospital routine.

Get a range that combines control, quality and reliability.

Nutritional Therapy Symposium:
From Evaluation to Clinical Action.

Access exclusive videos and content, scientific materials signed by Dr. Haroldo Falcão and much more at Prodiet Science.

Hospital Solutions. Care that Connects.

Discover the entire Prodiet hospital portfolio. A complete range of products that offer your patients something you can't do without: the best care.

1. Intensive Care Medicine in Brazil: profile of professionals and health services, 2024. 2HamiltonC, Boyce VJ. JPEN. 2013; 37(6): 808. 3.Schuetz P. BMJ Open. 2021;11(7):e046402. 4.Schuetz P. Clin Nutr. 2020;39(11):3361-3368. 5.Toulson Davisson Correia MI. JPEN J Parenter Enteral Nutr. 2021;45(7):1542-1550. 6.Shuetz et al. Lancet 2021; 398: 1927-38. 7.Toledo DO, et al. BRASPEN J. 2018;33(1):86-100 8.Milanez DS. JPEN J Parenter Enteral Nutr. 2023;47(6):754-765. 9.Petrucci M. Emerg. Care Med. 2025, 2(1),4. 10.Fazzini B, Märkl T. Crit Care. 2023;27(1):2. 11.van Zanten ARH. Crit Care. 2019;23(1):368. 12.Paulus MC, van Zanten ARH. Crit Care Clin. 2025;41(2):233-246. 13.Otani S. J Intensive Care. 2019;7:17. 14.De Brito-Ashurst I. JPEN J Parenter Enteral Nutr. 2016;40(7):913-923. 15.Blaser AR. Curr Opin Crit Care. 2015;21(2):142-153; Tirlapur N. Sci Rep. 2016;6:24691. 16.de Azevedo RP. Rev Bras Ter Intensiva. 2013;25(2):73-74; Mostafa SM. Br J Anaesth. 2003;91(6):815-819. 17.Escuro AA,Nutr Clin Pract. 2016;31(6):709-722. 18.Dou Y. Nutrients. 2022;14(16):3298. 19.Zhen H. Foods. 2024;13(24):3993 20.Giuntini EB, Menezes EW. Fully Recognized Functions of Nutrients: Dietary Fiber. ILSI Brazil Nutrition Committee. 2011 21.Patel S. Ann Med Surg (Lond). 2025;87(4):2020-2025 22.Kajbaf F. Therapy (2007) 4(1), 97-106. 23.Razavi Nematollahi L. Endocrines. 2023;4(3):521-535 24.Giuntini EB, et al. BRASPEN J. 2021;36(2):904 25.Zanini AC. Br J Nutr. 2023;130(7):1137-1143 26.Butteiger DN, et al. Clin Nutr. 2012;32(4):585-591 27.Reidy PT, et al. J Appl Physiol. 2014;116:1353-1364 28.McGraw NJ, et al. World J Nephrol. 2016;5(3):233-257 29.Sievenpiper JL. Can J Diabetes. 2018;42:S64-S79 30.Azadbakht L. Diabetes Care. 2008;31(4):648-654 31.Oosterwijk MM, et al. Kidney Int Rep. 2019;4(5):710-719 32.Viguiliouk E, et al. Nutrients. 2015;7(12):9804-9824 33. Konya J, et al. Front Endocrinol. 2019;10:296 34.Tokede AO, et al. Br J Nutr. 2015;114(6):831-843 35.Deibert P, et al. Int J Obes Relat Metab Disord. 2004;28(10):1349-1352 36.Vidal-Casariego A et al. Exp Clin Endocrinol Diabetes 2013; 121: 234-238 37.Diabetes Canada Clinical Practice Guidelines Expert Committee. Can J Diabetes. 2018;42(Suppl 1):S64-S79
Access the content